FDA seeks improvements in infusion pump safety
- Improving patient safety with intelligent infusion devices. Sullivan, Mark // American Journal of Health-System Pharmacy;9/1/2010, Vol. 67 Issue 17, p1415
The article reflects on the report by Breland that was published in the 2010 issue of "AJHP" on the implementation of intelligent infusion pumps at a community teaching hospital. He says that the report provides a platform for addressing issues related to the technology's evolution, its...
- 'Falsified' repairs of Baxter pumps result in still another Class I recall. // Medical Device Daily;7/27/2007, Vol. 11 Issue 142, p1
The article reports on the recall of Colleague and Flo-Gard line of infusion pumps manufactured by Baxter Healthcare. The U.S. Food and Drug Administration has recalled the infusion pump line as the serious, Class I variety. The campany claims the most recent recall is voluntary and pertaining...
- FDA clears Symbiq 3.13 infusion pump from Hospira. // Medical Device Daily;3/12/2012, Vol. 16 Issue 48, p1
The article reports on the 510(k) clearance granted by the U.S. Food and Drug Administration (FDA) to the Symbiq 313 infusion device of Hospira. Following the clearance, Hospira will work on upgrading the enhanced Symbiq device. A description of the new infusion pump is provided. It relates the...
- infusion pump. // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1194
A reference entry for "infusion pump" which refers to a pump employed to provide fluids into an artery, vein, or enteral tube is presented.
- FDA still not happy with Hospira's Indian facility. // Medical Device Daily;6/12/2013, Vol. 17 Issue 113, p8
The article reports on the warning issued by the U.S. Food and Drug Administration to Hospira due to serious sanitation violations by the infusion device company's facility in India.
- FDA launches initiative to reduce infusion pump risks. // Healthcare Purchasing News;Jun2010, Vol. 34 Issue 6, p8
The article discusses the launch of an initiative by the U.S. Food and Drug Administration (FDA) to reduce the safety issues associated with medication infusion pumps.
- Medtronic warning calls for outside certification. // Medical Device Daily;8/22/2012, Vol. 16 Issue 163, p6
The article reports on the U.S. Food & Drug Administration (FDA) warning suggesting that Minneapolis, Minnesota-based Medtronic meet with the agency to address the findings associated with the infusion pumps inspection.
- FDA orders recall of Baxter's infusion pumps. // Endocrine Today;Jun2010, Vol. 8 Issue 6, p24
The article discusses the order of the U.S. Food and Drug Administration (FDA) of the recall and destruction of all Colleague Volumetric Infusion Pumps used in the U.S.
- FDA safety initiative to address problems with infusion pumps. // Endocrine Today;Jun2010 Supplement, Vol. 8, p25
The article reports on an initiative launched by the U.S. Food and Drug Administration (FDA) to deal with the safety problems associated with external infusions pumps.